欣母沛预防和减少剖宫产术后出血的疗效分析  

Curative effect analysis of Hemabate preventing and decreasing postpartum hemorrhage after uterine-incision delivery

作　　者：许琴仙[1] 郑培兰[1] 

机构地区：[1]浙江省丽水市人民医院,浙江丽水323000

出　　处：《现代中西医结合杂志》2007年第23期3306-3307,共2页Modern Journal of Integrated Traditional Chinese and Western Medicine

摘　　要：目的探讨欣母沛在预防和减少有产后出血高危因素孕产妇剖宫产术后出血的疗效。方法选择有产科指征及产后出血高危因素者150例,随机分成3组各50例。宫体注射欣母沛0.25 mg为A组,米索前列醇0.4 mg塞入直肠内为B组,宫体注射催产素20 IU为C组。观察各组术后2 h及24 h出血量。结果A组术后2 h及24 h平均出血量均低于B组和C组(P<0.01)。结论有产后出血高危因素孕产妇剖宫产术时应用催产素20 IU后宫缩仍不佳即改用欣母沛疗效好。Objective It is to discuss the curative effect of Hemabate preventing and decreasing postpartum hemorrhage after uterine-incision delivery in puerpera with high risk factor of postpartum hemorrhage.Methods 150 puerperas who had obstetric indication and high risk factor of postpartum hemorrhage were chosen and randomly divided into three groups in which there were 50 cases.Group A was given Hemabate 0.25 mg injected into uterine corpus.Group B was given Misoprostol 0.4 mg stuffed into anus.Group C was given ...

关 键 词：欣母沛 产后出血 剖宫产术 高危因素 

分 类 号：R719.8[医药卫生—妇产科学]